|1.||Ito, Satoru: 2 articles (07/2014 - 01/2014)|
|2.||Okayasu, Isao: 2 articles (07/2014 - 01/2014)|
|3.||Matsuura, Masaaki: 2 articles (07/2014 - 01/2014)|
|4.||Fujiwara, Mutsunori: 2 articles (07/2014 - 01/2014)|
|5.||Arihiro, Seiji: 1 article (07/2014)|
|6.||Saruta, Masayuki: 1 article (07/2014)|
|7.||Arai, Yoshinori: 1 article (07/2014)|
|8.||Tajiri, Hisao: 1 article (07/2014)|
|9.||Matsuoka, Mika: 1 article (07/2014)|
|10.||Kato, Tomohiro: 1 article (07/2014)|
01/01/2000 - "PGE-MUM was determined by a simplified immunoassay of bicyclic PGE-MUM and analyzed for the influence of laxative administration and active/remission phases of ulcerative colitis. "
01/01/2000 - "The PGE-MUM levels were significantly correlated with our modified Talstad scores, clinical disease activity indices in ulcerative colitis. "
07/01/2014 - "Compared with CRP level, PGE-MUM level demonstrated better sensitivity for reflecting UC activity, especially in cases of histologic inflammation, and thus seems to be a better evaluator of mucosal healing. "
01/01/2014 - "This RIA method for PGE-MUM may be thus a sensitive and reliable biomarker for current inflammation, different from serum CRP."
07/01/2014 - "Since prostaglandin E2 production and colonic inflammation are associated, we evaluated whether prostaglandin E-major urinary metabolite (PGE-MUM) can be used as such a biomarker. "
05/20/1983 - "In the early phase of inflammation, the excretion of PGE-MUM and PGF-MUM was suppressed by administration of indomethacin. "
02/01/1980 - "3) Prednisolone and azathiopurine, which suppressed both primary and secondary lesions, increased the excretion of PGE-MUM over adjuvant control values on days 4 and 8. The facts described above suggest that the increase of endogenous PGE during days 4 to 8 may be important in the suppression of secondary lesions in adjuvant arthritis in rats."
|2.||Prostaglandins E (PGE)
|6.||prostaglandin F-main urinary metabolite